Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
Monika Vitkauskaitė(Vilnius University), Artūras Vinikovas(Vilnius University), Marius Miglinas(Vilnius University), Laurynas Rimševičius(Vilnius University), Agnė Čerkauskaitė(Vilnius University), Ernesta Mačionienė(Vilnius University), Eglė Ašakienė(Vilnius University)
Cited by 1Open Access
Abstract
Our case series showed that eculizumab is efficacious and safe in treating thrombotic microangiopathy, as well as it has positive effects on quality of life. Further extensive studies are required to develop unified treatment guidelines.
Related Papers
No related papers found
Powered by citation graph analysis